Introducing the Target 96 Proteomics Grant Opportunity
/
AGRF is excited to announce the launch of the Target 96 Proteomics Grant, offering researchers the opportunity to accelerate their biomarker discovery with Olink® Target 96, a high-throughput proteomics platform delivering unmatched sensitivity, specificity, and efficiency.
Through this grant, AGRF will award one free Olink Target 96 panel, enabling the successful applicant to measure 92 proteins across 88 samples using proximity extension assay (PEA) technology. This platform provides precise, reproducible insights into complex biological systems and supports a wide range of research areas, from disease biomarker discovery to clinical translation.
“We’re thrilled to support researchers layering proteomics and genomics to understand both mechanism and function,” said Desley Pitcher, Head of Strategic Business. “The Olink Target 96 platform offers powerful, scalable analysis that can transform the way we understand protein expression and function.”
About the Olink Target 96 Platform
The Olink Target 96 series is designed for high-quality, multiplex protein biomarker analysis. Each panel targets carefully curated protein groups relevant to key biological processes and disease areas — including cardiometabolic, inflammation, neurology, and oncology research.
How to Apply
Applications are open to all Australian and New Zealand researchers across academia, healthcare, and industry.
To apply, simply complete the short online application form outlining your project’s aims, impact, and intended use of the Olink Target 96 platform.
Find out more about the grant, here.
📅 Applications close: 5:00PM EADT 28 November 2025
🔗 Apply now: https://www.agrf.org.au/grant-application-page
Selection Criteria
Submissions will be assessed based on:
Scientific merit and innovation
Relevance and potential impact of the proposed study
Feasibility of completing the project using the Olink Target 96 platform
Potential for collaboration and downstream outcomes
The selected applicant will be announced by 8 January 2026.
At AGRF, we’re proud to empower Australian researchers with cutting-edge genomics and proteomics technologies that turn ideas into discoveries.
Apply today and take your research further with the AGRF Target 96 Proteomics Grant.
